Russian authorities are facing international scrutiny following the death of a 28-year-old laboratory worker in Siberia, which has raised concerns about a possible pneumonic plague exposure. Darya Shipilova, who was employed at the Irkutsk Anti-Plague Research Institute, died on October 2 after developing severe pneumonia. While Russia has denied any outbreak or connection to plague, the World Health Organization (WHO) continues to seek more detailed information.

Shipilova’s cause of death remains officially undetermined. Russian health officials have reported that she died from pneumonia of unknown origin and insist this illness is unrelated to her work with plague pathogens. Authorities have stated there is no risk of an epidemic and emphasized that nearly 5,000 tests conducted on contacts and environmental samples found no dangerous pathogens. Approximately 200 individuals who had contact with Shipilova were placed under quarantine or close monitoring, and the hospital where she died was also quarantined as a precaution.

Despite Russian denials, the WHO has expressed concern over the lack of comprehensive information and delayed communication regarding the incident and possible secondary cases. The agency has requested verification of unconfirmed reports indicating a second laboratory worker developed pneumonia of unknown cause, a claim Russian authorities have rejected as misinformation. WHO Director-General Tedros Adhanom Ghebreyesus highlighted the need for further data on laboratory results and the health status of all contacts to properly assess the risk.

Pneumonic plague, caused by the bacterium Yersinia pestis, can be transmitted through respiratory droplets in close contact, making it potentially dangerous due to its rapid onset and high fatality if untreated. The illness produces symptoms such as sudden fever, chills, chest pain, breathing difficulties, and sometimes bloody sputum. Unlike the more common bubonic form, which spreads mainly through infected flea bites, pneumonic plague can spread directly from person to person but generally requires close interaction. Early antibiotic treatment is essential and effective, and while a vaccine exists, it is typically reserved for high-risk groups like laboratory personnel.

The WHO has noted that plague cases still occur globally, with the majority reported in African countries such as the Democratic Republic of Congo and Madagascar, as well as occasional cases in the United States. Between 2019 and 2025, nearly 3,850 suspected plague cases and over 400 deaths were reported worldwide. Mongolia, which borders Russia, recorded 17 confirmed plague cases and seven deaths during the same period and has intensified surveillance efforts following the events in Siberia.

International concern has grown amid uncertainty. The United States and European Union have sought clarifications from Russian authorities, and the U.S. government has offered assistance to help with the investigation. Meanwhile, Russia continues to maintain that the situation is under control and denies any further cases linked to the laboratory. The WHO has urged transparency and timely sharing of information to mitigate public health risks and improve cross-border preparedness.